Double Thermal Ablation for Colon Polyps
(ABLATION Trial)
Trial Summary
What is the purpose of this trial?
Large (≥20mm) colorectal polyps often harbor areas of advanced neoplasia, making them immediate colorectal cancer (CRC) precursors. Such polyps have to be completely removed to prevent CRC and to avoid surgery and/or adjuvant therapy. The laterally spreading lesions (LSLs) are removed via endoscopic mucosal resection (EMR). However, recurrence is common. New techniques for LSL resection (hybrid argon plasma coagulation (h-APC) margin and base ablation) have shown a reduction in recurrence following the interventions. We hypothesize that performing hybrid argon plasma coagulation (h-APC) margin and base ablation during EMR of large (≥20mm) colorectal LSLs will lead to lower rates of lesion recurrence compared to Snare tip soft coagulation (STSC) margin ablation.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Double Thermal Ablation for Colon Polyps?
Research shows that argon plasma coagulation (APC), a component of the treatment, is effective and safe for treating various types of colon polyps, including flat colorectal adenomas and polyp remnants. Additionally, both snare tip soft coagulation (STSC) and APC have been used to reduce recurrence rates after polyp removal, indicating their effectiveness in managing colon polyps.12345
Is Double Thermal Ablation for Colon Polyps safe for humans?
Argon plasma coagulation (APC), a component of Double Thermal Ablation, has been used safely in treating colon polyps and other gastrointestinal conditions. Studies have shown that both APC and snare tip soft coagulation (STSC) are generally safe for use in humans, with no significant safety concerns reported.23456
How does the Double Thermal Ablation treatment for colon polyps differ from other treatments?
Double Thermal Ablation for colon polyps is unique because it likely involves a combination of thermal techniques, such as argon plasma coagulation (APC), which is a noncontact method that uses heat to treat tissue. This approach may offer a novel way to manage polyps by potentially reducing recurrence rates compared to traditional methods.12345
Eligibility Criteria
This trial is for adults over 18 who are having a specific type of colonoscopy to remove large colorectal polyps. They must be in good health, not have inflammatory bowel disease or blood clotting problems, and can't have cancerous or pedunculated polyps.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Endoscopic Mucosal Resection (EMR) with either h-APC or STSC margin ablation
Initial Follow-up
Telephone calls to assess possible adverse events within the first 14 days after EMR
Follow-up 1
Surveillance colonoscopy for assessment of recurrence 6 months after EMR
Follow-up 2
Surveillance colonoscopy for assessment of recurrence 18 months after EMR
Treatment Details
Interventions
- Hybrid Argon Plasma Coagulation (h-APC)
- Snare tip soft coagulation (STSC)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre hospitalier de l'Université de Montréal (CHUM)
Lead Sponsor